Abstract: An epidemiological health study compared the health status of residents of a town exposed to an accidental Catacarb chemical release from an adjacent oil refinery, with the health status of demographically similar residents of an unexposed town in the region. Few studies of Catacarb's effects on humans exist; however, animal studies have shown it to be a respiratory, gastro-intestinal, dermatological and visual irritant. As part of the study, health questionnaires assessing pre-and post exposure symptoms, illnesses and medication use were mailed to residents in both towns. Medication use is sometimes reported to be a more objective and reliable measure of health outcomes 1) . The current paper compared medication use of exposed and unexposed residents. Significant increases after exposure were found in the use of the following medications: antacid, asthma medication, cough and cold medication, eye medication, headache medication and sleep medication. These increases were consistent with reported symptoms, albeit of greater magnitude; no increase in medication use for other illnesses was reported. Medication use in this sample was consistent with patients' report of symptoms and may be a better measure of outcome.
Introduction
Chemical accidents have been increasing phenomena in the United States, concurrently with the rising gasoline production in the last decade 2) . Oil refineries are frequently located adjacent to poor residential communities 1, 3) . Residents studied in these communities have been shown to suffer adverse health effects following chemical accidents. One such chemical accident occurred in 1994 in the area of Crockett, California, situated adjacent to and downwind from a major oil refinery. A regeneration tower developed a hole, which resulted in a 16-day accidental release of 200 tons of Catacarb, a chemical solution used commonly by refineries to separate carbon monoxide and carbon dioxide from hydrogen.
Catacarb chemical composition
The major toxic chemicals in the 1994 Crockett Catacarb release were Diethanolamine (DEA), potassium metavanadate, potassium borate, and potassium carbonate.
Diethanolamine (DEA) is a highly toxic compound. No human studies are available on this compound but animal literature 4, 5) shows that it causes kidney, liver and heart problems, anemia, decreased sperm motility, necropathy of the brain and spinal cord, demyelination changes, skin alteration and death at very high doses.
The oil refinery's Material Safety Data Sheet (MSDS) for DEA indicates exposure limits of 0.46 to 3 ppm 6) . The exposure of the Crockett community to DEA was at this limit and higher.
Industrial Health 2002, 40, [335] [336] [337] [338] [339] [340] [341] [342] [343] [344] Vanadate is also a very toxic compound both when inhaled or when absorbed via other routes. The toxic effects and the toxicokinetics in humans and animals have been very well described and characterized in the literature [7] [8] [9] [10] [11] . Vanadate has been known to produce a wide range of effects on many systems in the body (respiratory, CNS, immune, cardiovascular, renal, and gastrointestinal systems) based on the dosage and the routes of exposure. In a study by governmental industrial hygienists, the exposure of five human volunteers to respirable vanadium pentoxide dust at concentrations of 0.2 mg/m 3 for 8 hrs caused severe upper respiratory tract irritation in the form of persistent productive cough 12) . Exposure to higher levels of vanadate (over 0.5 mg/m 3 for up to 2 weeks) has produced acute respiratory symptoms in humans which can persist for up to 2 weeks after removal of the exposure 13) , and it has been reported that the toxic effects of vanadate in rats are cumulative 8) . Exposure to moderate levels of potassium carbonate by inhalation can cause irritation of the mucous membrane of the eyes and upper respiratory system. This chemical has irritant and caustic actions similar to that of potassium hydroxide, but less severe 14) . Damage to the mucous membrane of the eyes and the respiratory system is expected at the exposure levels incurred during the 1994 Catacarb release.
Exposure to potassium borate and diethanolamine at the projected levels are also expected to cause irritation to the mucous membrane of the eyes and the respiratory systems.
Description of the exposed community
The town of Crockett has 3300 predominantly workingclass residents and is medically underserved. It neither has a medical clinic, nor a single physician practicing within the town limits. The exposure mobilized the town's community leaders who negotiated "Good Neighbor" agreements with the refinery, which resulted in the funding of an epidemiological health study of the community 3) . Following the accidental Catacarb release residents quickly reported such early acute symptoms as headache, diarrhea, fatigue, vomiting, disorientation, flu-like symptoms and general weakness. These acute adverse health symptoms enabled the town leaders to also successfully negotiate temporary refinery funding for a Good Neighbor Clinic (GNC) in their town for a period of approximately nine months following the release. Over 1500 people (including 1000 Crockett residents, representing almost one third of the town's population) were medically evaluated for health effects associated with the Catacarb release by the Good Neighbor Clinic. Consistent with the independent findings of the community epidemiological study 3) , GNC physicians also reported new onset of upper respiratory, eye, gastrointestinal, and neurological conditions, as well as psychological problems, including anxiety, depression and sleep disturbance.
The existing literature on medication use and chemical exposure is relatively scarce. However, a few reports exist, linking increased medication use to chemical exposures. Dayal, et al. 1) found increased medication use for breathingrelated symptom reports and hydrofluoric acid exposure from an oil refinery in a community in Texas. Doucet 15) postulated that the Desert Storm Syndrome is an example of multiple assaults upon the body's immune system with subsequent increases in symptoms and in medications. Pisati, et al. 16) report an association of exposure to toluene diisocyanate (TDI) with increased and worsening asthmatic symptoms and an increased need for medication. Two independent studies of toxic waste landfills both showed adverse health effects and increased medication use in nearby community residents 17, 18) . According to Dayal 1) , medication use may be a more objective and reliable measure of health outcomes in exposed populations. In his 1994 study of exposure to hydrofluoric acid following a chemical spill in Texas, he found significant correlations between medication use and exposure, and between symptom reports and medication. For our study, analysis of the available medication data from the larger epidemiological study was undertaken. The current paper compares medication use in Catacarb exposed and unexposed residents.
Materials and Methods
A community health study was requested by the exposed town residents within one month of the Catacarb release and successfully negotiated with the refinery as one of their Good Samaritan agreements. The study took place six months after the release (Labor Day 1995). As noted above, the release was caused by a refinery regeneration tower, which developed a hole and, for 16 days, spewed toxic material into the atmosphere that drifted toward the nearby town of Crockett. As the release worsened and residents noticed sticky brown deposits on cars and houses in the town, they also developed health complaints forcing the refinery to temporarily shut down its operations.
In a previous paper 3) , the authors compared prevalence rates of symptoms and illnesses in the exposed population to those of a carefully selected nearby non-exposed town, similar in size and demographic characteristics based on the US Census data for the region (Santa Venetia).
Demographic characteristics of exposed and non-exposed residents are shown in Table 1 . The non-exposed town's residents were similar to those of the exposed town's residents in age, number in household, number of children, and gender. However, the non-exposed sample was slightly more educated, higher salaried and included slightly more whites than the exposed town. Baseline prevalence rates (prior to exposure) for illnesses and health symptoms were similar in both groups.
Procedure
Once the study was funded, informational meetings were held to educate the residents of both towns on the study's value and the importance of their participation. Confidential health questionnaires were mailed to each household and residents were asked to complete one set of questionnaires for each of the two primary adults. Customary survey methods, including follow-up letters and telephone calls, were employed to enhance response rate, and are described in more detail in Bowler et al., 1997 3) . Identical questionnaires were used for both the exposed and non-exposed towns with the exception of questions pertaining to exposure variables. In all 3333 questionnaires were mailed, 1523 questionnaires to exposed households and 1810 to non-exposed households. The overall response rate was 43.1%: 38.9% for the exposed group and 46.6% for the non-exposed group.
One month after the completed questionnaires were received, a randomly selected sample of 200 respondents from both towns received a brief second questionnaire eliciting a further checklist identification of representative symptoms after the release in order to assess the questionnaires' reproducibility. Symptom reporting was found to be reliable in terms of both the type and the number of symptoms. Moreover, medical records of a randomly selected group of 35 respondents available from the GNC established community clinic were reviewed to assess concordance of patients' symptom reports and report of medication use with physician's medical records notations.
Health questionnaire
In addition to general demographic items, the questionnaire included a checklist of symptoms found in other studies to be sensitive to chemical exposure 19) . Table 2 shows individual items contained in the symptom categories of respiratory, dermatological, visual, headache/chemical sensitivity, depression, anxiety and sleep disorder. Participants were asked to indicate for each item whether or not they had experienced that particular symptom during the previous month (in this case five to six months after exposure). Responses were summed for each category. In addition, two subscales for depression and anxiety from the Brief Symptom Inventory (BSI) by Derogatis 20) were included. Scoring of the two BSI scales followed the guidelines in the manual.
The questionnaire also included 'doctor diagnosed' illnesses and inquired if any of these illnesses had worsened within the past six months. (The chemical release had occurred immediately prior to Labor Day 1994 and the questionnaires were collected 6 months after Labor Day, making the 6 month time frame a convenient unit of time for optimal recall.) New onset illnesses were indicated by the date of diagnosis and worsened illness (for those who had been diagnosed prior to the release) was indicated by the illness status after the release. Illnesses typically associated with chemical exposure (respiratory, dermatological, eye and immunologic) [21] [22] [23] [24] [25] [26] [27] [28] were included, as well as other illnesses.
Medication use was investigated and medication categories were derived after consultation with three physicians knowledgeable in the areas of both chemical exposure and medications. All major body systems were considered and especially medications, both over the counter and by prescription, relevant to chemical exposure were included. The latter list specifically included medications for respiratory, dermatological, eye and immunologic conditions. Medication use for anxiety and depression was also assessed. Respondents were also asked to indicate if their medication use had changed (new and increased use) in the post-release period.
In terms of exposure characteristics, exposed participants were also asked if they had observed any brown sticky deposits (residuals of Catacarb) on either their car or house, and whether they gardened during the 1994 Labor Day weekend, the days of the highest levels of Catacarb release.
Estimates of exposure concentrations of the components of Catacarb were determined by a board-certified toxicologist, based on the estimates provided by a refinery company risk assessment 29) . For estimated human exposure to Catacarb components in the Crockett accident, please refer to Table 3 .
Statistical analysis
Questionnaires that remained incomplete after repeated telephone contacts or were otherwise invalid were excluded in the final analysis.
Demographic variables for the two towns were analyzed with unpaired t tests and chi-squares. A linear generalized estimating equation (GEE ) adjusting for gender, education and race was used to analyze the outcome variables. The Headaches at least twice a week A lower tolerance for alcohol Nausea not caused by something you ate specification of the working correlation matrix is exchangeable to take into account the within household correlation factor. This factor is used in the estimation to obtain the robust point estimates and 95% confidence intervals of the variables of interest. The estimated adjusted odds ratios and risk difference ratios were computed and 95% confidence intervals were used for the presence of medication use before and after the release, and for medication use by exposure variables.
Results
The questionnaire mailing yielded 509 usable questionnaires from the exposed and 655 from the nonexposed towns. As can be seen in Table 1 , the sample was primarily white, working middle class and slightly more educated than the general population. The observed increase in symptoms and illnesses in the exposed population are reported elsewhere 3) . In summary, after controlling for the effects of gender, education, race and household cluster, postexposure increases (p<0.05) in respiratory, visual, and dermatological symptoms were found (O.R. Table 4 shows the presence of a selection of reported symptom categories for both towns. Estimated adjusted odds ratios indicate that the exposed residents report experiencing significantly more symptoms than the non-exposed residents. Table 5 shows the percent of doctor diagnosed illnesses for each town, both prior to and post-Labor Day. Residents who endorsed illnesses prior to the exposure were asked to report if their illnesses had worsened; residents who did not suffer from illness prior to the release were asked about new onset. Adjusted odds ratios and risk differences of residents' worsening or new onset illnesses in the exposed town were between 2.0 to 24.0. The authors have also reported elsewhere 3) on the good to excellent reproducibility coefficients of the questionnaires that were evaluated for the first and second responding for each town. This finding indicates better than adequate reliability of residents' self report. In addition to these reproducibility results, we have reported elsewhere on the medical review of independent physician case histories and notes, which indicated a high concordance between symptoms reported in the questionnaire and those reported to physicians during medical visits. Again, this would indicate good reliability of the self-report, especially where the exposed residents are concerned.
As noted above, medication use report may be an even more reliable measure of health outcome than self-report of symptoms. Therefore, medication use of both towns was evaluated and is shown in Tables 6a and 6b. Table 6a shows a similar relative risk for medication use prior to the release in the two towns, with odds ratios ranging between 0.92 to 1.22. Prior to the release, the exposed group reported the use of slightly more medication for respiratory and immunologic health problems but not for skin, psychiatric or other problems prior to the release. After the release, a dramatic increase in medication use for the exposed town is noted (Table 6b ) with odds ratios ranging from 1.7 to 19, whereas this is not the case for the unexposed town. Table 7 shows odds ratios for medication use in the exposed town in relation to the above mentioned exposure characteristics (seeing sticky brown deposits on car or house and gardening during Labor Day weekend). Odds ratios above 1.5 were found for respondents seeing the brown sticky substance on their cars for asthma, cough, cold, eye medicine use and for antacids use. Similarly, odds ratios above 1.5 were found for residents who reported seeing the substance on their house, for the use of cough and cold medicine, antidepressants, antacid and sleeping medication.
Discussion
A review of the literature on the effects of Catacarb exposure on animals or humans has shown that the symptoms and illnesses reported here are typically found as sequelae of such chemical exposures. While immediate symptom and illness reports are frequently taken after chemical accidents, few studies have looked at medication use. It has been proposed by Dayal et al. 1) that medication use may be a more reliable and objective measure of health outcomes than symptom reports alone.
As noted above, the main findings of this study indicate that the residents of the exposed community reported significantly increased symptoms and illnesses. Moreover, they also reported a significantly increased use of several types of medications following the Catacarb release. These medications were usually prescribed to alleviate symptoms of upper respiratory, eye, gastrointestinal and neurological conditions, and their use was consistent with increased symptom reports in these domains by the exposed residents. The exposed residents in this study reported both a greater prevalence of new onset use of medication and/or a significantly increased use of existing medication to alleviate their symptoms. As can be seen in Fig. 1 , odds ratios for respiratory, dermatological and eye medication use were even higher than those for corresponding symptoms and illnesses. It is known from the medical records review conducted as part of this study that residents' report on medication use have good concordance with the sample of medical records reviewed by physicians. Medication use thus appears to be at least consistent with symptom report. If considered a more objective and reliable measure of outcome, it would again indicate significant long-term negative effects, possibly to a greater degree than assumed on the basis of symptom report alone. It is noteworthy that the exposed residents did not report increases in use of medication for illnesses unrelated to chemical toxic exposure -arthritis; antibiotics; elevated blood pressure and cholesterol; cardiac illnesses; diabetes. The exposed residents also did not report taking more herbal medicines than the non-exposed group. Of particular note is the doubled prevalence rate for respiratory and eye medication use in residents who noted Catacarb deposits on their car and their house. It can be hypothesized that individuals who had direct contact with Catacarb residue incurred greater levels of exposure and thus were more affected by the toxic chemicals, than individuals who did not. The specificity of exposed residents' medication use for associated illnesses and symptoms is suggestive of the reliability of the exposed residents' responses. This also lends further credence to the validity of the reported results and would argue against a generalized inflated self-report of health complaints by the exposed.
In conclusion, this study shows that the residents who were exposed to the Catacarb release not only developed 
